vs
Assertio Holdings, Inc.（ASRT）与R F INDUSTRIES LTD（RFIL）财务数据对比。点击上方公司名可切换其他公司
R F INDUSTRIES LTD的季度营收约是Assertio Holdings, Inc.的1.7倍（$22.7M vs $13.5M），R F INDUSTRIES LTD同比增速更快（22.9% vs -57.9%），过去两年R F INDUSTRIES LTD的营收复合增速更高（29.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商，旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖，目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
ASRT vs RFIL — 直观对比
营收规模更大
RFIL
是对方的1.7倍
$13.5M
营收增速更快
RFIL
高出80.9%
-57.9%
两年增速更快
RFIL
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $22.7M |
| 净利润 | — | $173.0K |
| 毛利率 | — | 36.8% |
| 营业利润率 | -86.7% | 4.0% |
| 净利率 | — | 0.8% |
| 营收同比 | -57.9% | 22.9% |
| 净利润同比 | — | 172.7% |
| 每股收益（稀释后） | $-4.54 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTRFIL
| Q4 25 | $13.5M | $22.7M | ||
| Q3 25 | $49.5M | $19.8M | ||
| Q2 25 | $29.2M | $18.9M | ||
| Q1 25 | $26.5M | $19.2M | ||
| Q4 24 | $32.2M | $18.5M | ||
| Q3 24 | $29.2M | $16.8M | ||
| Q2 24 | $31.1M | $16.1M | ||
| Q1 24 | $32.4M | $13.5M |
净利润ASRTRFIL
| Q4 25 | — | $173.0K | ||
| Q3 25 | $11.4M | $392.0K | ||
| Q2 25 | $-16.4M | $-245.0K | ||
| Q1 25 | $-13.5M | $-245.0K | ||
| Q4 24 | — | $-238.0K | ||
| Q3 24 | $-2.9M | $-705.0K | ||
| Q2 24 | $-3.7M | $-4.3M | ||
| Q1 24 | $-4.5M | $-1.4M |
毛利率ASRTRFIL
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 24.5% |
营业利润率ASRTRFIL
| Q4 25 | -86.7% | 4.0% | ||
| Q3 25 | 23.2% | 3.6% | ||
| Q2 25 | -27.5% | 0.6% | ||
| Q1 25 | -50.0% | 0.3% | ||
| Q4 24 | -41.9% | 0.5% | ||
| Q3 24 | -10.4% | -2.5% | ||
| Q2 24 | -11.6% | -2.6% | ||
| Q1 24 | -13.4% | -15.5% |
净利率ASRTRFIL
| Q4 25 | — | 0.8% | ||
| Q3 25 | 23.1% | 2.0% | ||
| Q2 25 | -56.0% | -1.3% | ||
| Q1 25 | -51.1% | -1.3% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -10.0% | -4.2% | ||
| Q2 24 | -11.8% | -26.7% | ||
| Q1 24 | -13.9% | -10.1% |
每股收益（稀释后）ASRTRFIL
| Q4 25 | $-4.54 | $0.01 | ||
| Q3 25 | $0.11 | $0.04 | ||
| Q2 25 | $-0.17 | $-0.02 | ||
| Q1 25 | $-0.14 | $-0.02 | ||
| Q4 24 | $-3.28 | $-0.02 | ||
| Q3 24 | $-0.03 | $-0.07 | ||
| Q2 24 | $-0.04 | $-0.41 | ||
| Q1 24 | $-0.05 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $35.2M |
| 总资产 | $267.0M | $73.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTRFIL
| Q4 25 | $63.4M | $5.1M | ||
| Q3 25 | $93.4M | $3.0M | ||
| Q2 25 | $98.2M | $3.6M | ||
| Q1 25 | $87.3M | $1.3M | ||
| Q4 24 | $100.1M | $839.0K | ||
| Q3 24 | $88.6M | $1.8M | ||
| Q2 24 | $88.4M | $1.4M | ||
| Q1 24 | $80.7M | $4.5M |
总债务ASRTRFIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTRFIL
| Q4 25 | $94.0M | $35.2M | ||
| Q3 25 | $105.8M | $34.8M | ||
| Q2 25 | $93.3M | $34.2M | ||
| Q1 25 | $108.5M | $34.2M | ||
| Q4 24 | $121.1M | $34.1M | ||
| Q3 24 | $130.5M | $34.1M | ||
| Q2 24 | $132.2M | $34.6M | ||
| Q1 24 | $134.5M | $38.7M |
总资产ASRTRFIL
| Q4 25 | $267.0M | $73.0M | ||
| Q3 25 | $319.8M | $73.2M | ||
| Q2 25 | $273.8M | $72.7M | ||
| Q1 25 | $286.4M | $70.4M | ||
| Q4 24 | $284.7M | $71.0M | ||
| Q3 24 | $276.0M | $71.9M | ||
| Q2 24 | $279.4M | $72.8M | ||
| Q1 24 | $282.0M | $79.1M |
负债/权益比ASRTRFIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $2.1M |
| 自由现金流经营现金流 - 资本支出 | — | $2.0M |
| 自由现金流率自由现金流/营收 | — | 9.0% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | 12.13× |
| 过去12个月自由现金流最近4个季度 | — | $4.3M |
8季度趋势，按日历期对齐
经营现金流ASRTRFIL
| Q4 25 | $-30.0M | $2.1M | ||
| Q3 25 | $-4.8M | $-311.0K | ||
| Q2 25 | $19.1M | $2.2M | ||
| Q1 25 | $-12.5M | $601.0K | ||
| Q4 24 | $11.5M | $-244.0K | ||
| Q3 24 | $-35.0K | $2.4M | ||
| Q2 24 | $7.4M | $197.0K | ||
| Q1 24 | $7.5M | $840.0K |
自由现金流ASRTRFIL
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-419.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $574.0K | ||
| Q4 24 | — | $-418.0K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $28.0K | ||
| Q1 24 | — | $697.0K |
自由现金流率ASRTRFIL
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 5.2% |
资本支出强度ASRTRFIL
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.1% |
现金转化率ASRTRFIL
| Q4 25 | — | 12.13× | ||
| Q3 25 | -0.42× | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
